Bull Of The Day - GW Pharmaceuticals

"We do real science and produce medicines with safety and efficacy... Epidiolex is not marijuana, it is CBD approved by the FDA. We're only reporting two months of sales, so some caution is warranted... we're at the beginning of the journey with Epidiolex and looking at other uses for it."

I have been telling long-term healthcare investors for months that this is a stock to buy on every dip toward $140. This will be one to accumulate on pullbacks as the science and the sales have proven worthy of a blockbuster trajectory.

1 2 3 4
View single page >> |

Disclosure: I own GWPH shares for the Zacks Healthcare Innovators portfolio.

Kevin Cook is a Senior Stock Strategist for Zacks Investment Research where he runs the more

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.